Skip to content
Head to head

Stepan vs Linde

Side-by-side on the measures that matter, with a plain-English read. Full detail: SCL · LIN

Updated 6 minutes ago

1-year performance, rebased to 100

SCL +53.3%LIN +22.0%
Linde edges it on the scoreable measures. Linde trades cheapest on trailing earnings; Linde earns the most per share.
SCLLIN
Snapshot
SectorSpecialty ChemicalsSpecialty Chemicals
Last price63.48502.83
Change today-2.34%-1.45%
1-year return+53.4%+24.8%
Market cap$1.44B$230.84B
52-week range41.71 – 72.67384.00 – 546.40
Valuation
P/E (TTM)334.1133.39
P/E percentile, own 5-yr range99th57th
P/B1.185.86
Dividend yield2.49%1.25%
Profitability & growth
EPS (TTM)2.0514.61
Net profit (TTM)$46.61M$6.71B
Revenue (TTM)$2.53B$36.24B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+17.3%+9.2%
Gross margin12.0%47.9%
Operating margin3.6%27.1%
Net margin0.2%19.3%
Free cash flow (TTM)$4.56M$5.08B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership91.9%88.6%
Insider activity (12mo)24 buy / 12 sell27 buy / 16 sell
Short interest (% of float)3.0%1.4%
Analyst consensus100% buy (1)94% buy / 6% hold (16)
Analyst price target$85 (+34%)$570 (+13%)
StockVane view
StockVane Quant RatingC (89)C (69)
Company
Employees2,32865,177
Founded19322017

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.